dihydroxyphenylalanine has been researched along with Eye Cancer, Retinoblastoma in 2 studies
Dihydroxyphenylalanine: A beta-hydroxylated derivative of phenylalanine. The D-form of dihydroxyphenylalanine has less physiologic activity than the L-form and is commonly used experimentally to determine whether the pharmacological effects of LEVODOPA are stereospecific.
dopa : A hydroxyphenylalanine carrying hydroxy substituents at positions 3 and 4 of the benzene ring.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Klaidman, LK | 1 |
| Tombran-Tink, J | 1 |
| Adams, JD | 1 |
| Johnson, LV | 1 |
| Yorek, MA | 1 |
| Strom, DK | 1 |
| Spector, AA | 1 |
2 other studies available for dihydroxyphenylalanine and Eye Cancer, Retinoblastoma
| Article | Year |
|---|---|
Effects of medium conditioned by retinal pigmented epithelial cells on neurotransmitter phenotype in retinoblastoma cells.
Topics: Cell Differentiation; Chromatography, High Pressure Liquid; Culture Media, Conditioned; Dihydroxyphe | 1993 |
Synthesis and high affinity uptake of serotonin and dopamine by human Y79 retinoblastoma cells.
Topics: 3,4-Dihydroxyphenylacetic Acid; 5-Hydroxytryptophan; Biological Transport; Cell Line; Dihydroxypheny | 1987 |